Cite
Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type.
MLA
Senff, Nancy J., et al. “Fine-Mapping Chromosomal Loss at 9p21: Correlation with Prognosis in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.” The Journal of Investigative Dermatology, vol. 129, no. 5, May 2009, pp. 1149–55. EBSCOhost, https://doi.org/10.1038/jid.2008.357.
APA
Senff, N. J., Zoutman, W. H., Vermeer, M. H., Assaf, C., Berti, E., Cerroni, L., Espinet, B., de Misa Cabrera, R. F., Geerts, M.-L., Kempf, W., Mitchell, T. J., Paulli, M., Petrella, T., Pimpinelli, N., Santucci, M., Whittaker, S. J., Willemze, R., & Tensen, C. P. (2009). Fine-mapping chromosomal loss at 9p21: correlation with prognosis in primary cutaneous diffuse large B-cell lymphoma, leg type. The Journal of Investigative Dermatology, 129(5), 1149–1155. https://doi.org/10.1038/jid.2008.357
Chicago
Senff, Nancy J, Willem H Zoutman, Maarten H Vermeer, Chalid Assaf, Emilio Berti, Lorenzo Cerroni, Blanca Espinet, et al. 2009. “Fine-Mapping Chromosomal Loss at 9p21: Correlation with Prognosis in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.” The Journal of Investigative Dermatology 129 (5): 1149–55. doi:10.1038/jid.2008.357.